H.C. Wainwright Affirms Buy Rating on Alto Neuroscience (ANRO), Sets $10 PT
On Tuesday, H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on Alto Neuroscience Inc. (NYSE:ANRO) and set a price target of $10.00.
Alto Neuroscience Inc. (ANRO)
Market is closed
News
- Displaying 2
Insiders are Piling into These 10 Healthcare Stocks in 2024
In this article, we will take a detailed look at Insiders are Piling into These 10 Healthcare Stocks in 2024. For a quick overview of such stocks, read our article Insiders are Piling into These 5 ...
Billionaire Hedge Funds
